HAE is a rare genetic disorder that occurs in about 1 in 10,000 to 1 in 50,000 people worldwide.
The clinical course of HAE attacks is unpredictable.
HAE is characterized by episodes of swelling (edema attacks) in different areas of the skin or the internal organs.
In HAE, uncontrolled production of a substance called plasma kallikrein occurs. This leads to the release of too much bradykinin in your bloodstream. Too much bradykinin leads to symptoms like swelling and pain (HAE attack).
Reprinted with permission of www.haeimages.com
Courtesy of Bas M, et al. Allergy 2006;61(12):1490-1492.